Corporate ActionJun 10, 2026, 04:16 PM
IDEAYA Biosciences Raises $323.6M in Equity Offering
AI Summary
IDEAYA Biosciences, Inc. completed an equity offering, generating approximately $323.6 million in net proceeds. The offering included the sale of 7,222,225 shares of common stock, which incorporated the full exercise of the underwriters' option, and pre-funded warrants to purchase 5,555,576 shares. The transaction was executed under an underwriting agreement with J.P. Morgan Securities LLC, Jefferies LLC, TD Securities (USA) LLC, UBS Securities LLC, and Cantor Fitzgerald & Co.
Key Highlights
- IDEAYA Biosciences raised approximately $323.6 million in net proceeds from the offering.
- The company sold 7,222,225 shares of common stock, including the full exercise of the underwriters' option.
- Pre-funded warrants to purchase 5,555,576 shares were also sold.
- The public offering price was $27.00 per share and $26.9999 per pre-funded warrant.
- Underwriters' option for 1,666,669 additional shares was fully exercised.
- Directors and executive officers are subject to a 60-day lock-up period.
Price Impact
More from IDYA